Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Chubb
Johnson and Johnson
Accenture
Merck
Moodys
Citi
Daiichi Sankyo
Federal Trade Commission

Generated: June 24, 2018

DrugPatentWatch Database Preview

Trazodone hydrochloride - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for trazodone hydrochloride and what is the scope of trazodone hydrochloride freedom to operate?

Trazodone hydrochloride
is the generic ingredient in four branded drugs marketed by Angelini Pharma, Pragma Pharms Llc, Accord Hlthcare, Alvogen, Am Therap, Apotex, Apotex Inc, Aurolife Pharma Llc, Fosun Pharma, Mylan, Mylan Pharms Inc, Pliva, Quantum Pharmics, Sun Pharm Industries, Teva, Teva Pharms Usa, Torrent Pharms Ltd, Usl Pharma, Vintage, Watson Labs, and Zydus Pharms Usa Inc, and is included in thirty-one NDAs. There are three patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Trazodone hydrochloride has one hundred and four patent family members in thirty-three countries.

There are thirteen drug master file entries for trazodone hydrochloride. Forty-three suppliers are listed for this compound.
Pharmacology for trazodone hydrochloride
Medical Subject Heading (MeSH) Categories for trazodone hydrochloride
Synonyms for trazodone hydrochloride
1,2,4-Triazolo(4,3-a)pyridin-3(2H)-one, 2-(3-(4-(3-chlorophenyl)-1-piperazinyl)propyl)-, monohydrochloride
1,2,4-triazolo[4,3-a]pyridin-3(2H)-one hydrochloride
1,2,4-Triazolo[4,3-a]pyridin-3(2H)-one, 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-, monohydrochloride
1,2,4-Triazolo[4,3-a]pyridin-3(2H)-one,2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-,hydrochloride (1:1)
1,4-Triazolo[4,3-a]pyridin-3(2H)-one, 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-, monohydrochloride
19666-36-5
2-(3-(4-(3-Chlorophenyl)-1-piperazinyl)propyl)-s-triazolo(4,3-a)pyridin-3(2H)-one HCl
2-(3-(4-(3-Chlorophenyl)piperazin-1-y)propyl)-1,2,4-triazolo(4,3-a)pyridine-3(2H)-one hydrochloride
2-(3-(4-(3-chlorophenyl)piperazin-1-yl)propyl)-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one hydrochloride
2-(3-(4-(3-Chlorophenyl)piperazin-1-yl)propyl)-1,2,4-triazolo(4,3-a)pyridin-3(2H)-one hydrochloride
2-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-s-triazolo(4,3-a)pyridin-3(2H)-one monohydrochloride
2-[3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl]-
2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one hydrochloride
2-[3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl]-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one hydrochloride
2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one hydrochloride
2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one;hydrochloride
2-[3-[4-(m-Chlorophenyl)-1-piperazinyl]propyl]-s-triazolo[4,3-a]pyridin-3(2H)-one monohydrochloride
2-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-2H,3H-[1,2,4]triazolo[4,3-a]pyridin-3-one hydrochloride
2-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one hydrochloride
2-{3-[4-(3-chlorophenyl)piperazinyl]propyl}-4-hydro-1,2,4-triazolino[4,3-a]pyr idin-3-one, chloride
25332-39-2
332T392
4CA-1276
6E8ZO8LRNM
A813950
A817789
AB2000676
AC-6779
AC1L1Y2P
AC1Q3BFE
AF 1161
AF-1161
AK-51734
AKOS015897762
AN-9680
Apo-Trazodone
Azona
BC215367
Bimaran
C19H22ClN5O.HCl
C19H23Cl2N5O
CAS-25332-39-2
CCG-40299
CHEBI:9655
CHEMBL1200798
CPD000058520
CS-2592
CT0209
CTK4F5497
D00820
Desyrel
Desyrel (TN)
Devidon
DSSTox_CID_24626
DSSTox_GSID_44626
DSSTox_RID_80361
DTXSID8044626
EINECS 243-216-2
EINECS 246-855-5
EU-0101159
FT-0659024
HE067225
HMS1568L06
HMS1922G09
HSDB 7048
HY-B0478
I13-027
J-015941
J10153
Jsp005028
K-6661
KB-831
KS-00000ZWU
KS-5100
LP01159
LS-156736
MCULE-3098459714
MFCD00079603
MLS000069698
MLS000758230
MLS001148260
MLS001424009
Molipaxin
MolPort-001-684-664
NC00046
NCGC00016035-02
NCGC00016035-13
NCGC00094420-01
NCGC00094420-02
NCGC00094420-03
NCGC00094420-04
NCGC00256807-01
NCGC00261844-01
NSC 292811
NSC-292811
NSC-758393
NSC292811
NSC758393
Oleptro
Opera_ID_850
Pharmakon1600-01503121
Pragmazone
Prestwick_478
PubChem15888
s-Triazolo(4,3-a)pyridin-3(2H)-one, 2-(3-(4-(m-chlorophenyl)-1-piperazinyl)propyl)-, monohydrochloride
s-Triazolo(4,3-a)pyridin-3(2H)-one, 2-(3-(4-(m-chlorophenyl)-1-piperazinyl)propyl)-,monohydrochloride
S-Triazolo[4, 2-[3-[4-(m-chlorophenyl)-1-piperazinyl]propyl]-, monohydrochloride
S-Trizolo[4, 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-, hydrochloride
S2582
SAM001247045
SC-16187
SCHEMBL61754
SMR000058520
SPECTRUM1503121
ST2407780
ST51015149
T 6154
Thombran
Tombran
Tox21_110286
Tox21_110286_1
Tox21_302685
Tox21_501159
Trazodone (hydrochloride)
Trazodone Hcl
Trazodone hydrochloride (Desyrel)
Trazodone hydrochloride (JAN/USP)
Trazodone hydrochloride [USAN:JAN]
Trazodone hydrochloride [USAN:USP:JAN]
Trazodone Hydrochloride 1.0 mg/ml in Methanol (as free base)
Trazodone hydrochloride, >=99% (HPLC), powder
Trazodone hydrochloride, United States Pharmacopeia (USP) Reference Standard
Tritico
Triticum
UNII-6E8ZO8LRNM
VA11904
WLN: T56 ANVNNJ C3- AT6N DNTJ DR CG &GH
Z1550675462

US Patents and Regulatory Information for trazodone hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pragma Pharms Llc DESYREL trazodone hydrochloride TABLET;ORAL 018207-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Accord Hlthcare TRAZODONE HYDROCHLORIDE trazodone hydrochloride TABLET;ORAL 206923-001 Sep 8, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Pharms Inc TRAZODONE HYDROCHLORIDE trazodone hydrochloride TABLET;ORAL 090514-002 Jun 2, 2009 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Apotex TRAZODONE HYDROCHLORIDE trazodone hydrochloride TABLET;ORAL 071258-001 Mar 25, 1987 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for trazodone hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pragma Pharms Llc DESYREL trazodone hydrochloride TABLET;ORAL 018207-003 Mar 25, 1985 ➤ Try a Free Trial ➤ Try a Free Trial
Pragma Pharms Llc DESYREL trazodone hydrochloride TABLET;ORAL 018207-003 Mar 25, 1985 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for trazodone hydrochloride

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,414,919 Sustained drug release composition ➤ Try a Free Trial
8,795,723 Sustained drug release compositions ➤ Try a Free Trial
8,962,019 Sustained drug release composition ➤ Try a Free Trial
9,439,866 Trazodone composition for once a day administration ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Chinese Patent Office
Covington
Accenture
Fish and Richardson
Dow
Julphar
Moodys
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.